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Abstract
Objective: To describe the main controversies about resuscitation procedures performed in extremely low birth
weight infants in the delivery room.
Sources of data: Systematic review including articles from MEDLINE, SciELO and Cochrane Library, and
abstracts published in national and international proceedings, using the keywords resuscitation, asphyxia, and
newborn infant.
Summary of the findings: The main controversies concern the oxygenation and ventilation of extremely low
birth weight infants. The effects of oxygen concentrations between 21 and 100% need to be addressed. Appropriate
inspiratory pressure, lung volume, and positive end-expiratory pressure parameters also need to be established in
order to decrease barotrauma and volutrauma. The benefits of nasal continuous positive airway pressure may be
determined through randomized clinical trials. On top of that, manual resuscitation devices have to be developed
in order to optimize these ventilatory parameters and to reduce lung injury. So far, clinical trials on the administration
of epinephrine, volume expanders, and sodium bicarbonate to extremely low birth weight infants have not been
published. In addition, the main ethical dilemma concerns the decision of health professionals and parents not to
initiate resuscitation procedures at very low gestational ages.
Conclusions: In the future, guidelines may be modified based on the results of randomized and controlled
clinical trials, as well as neurodevelopmental follow-up studies, involving extremely low birth weight infants
submitted to resuscitation procedures in the delivery room.
J Pediatr (Rio J). 2005;81(1 Suppl):S3-S15: Resuscitation, asphyxia neonatorum, newborn infant.
Controversies about the resuscitation
of extremely preterm infants
in the delivery room
Maria Fernanda Branco de Almeida,1 Ruth Guinsburg2
0021-7557/05/81-01-Supl/S3
Jornal de Pediatria
Copyright © 2005 by Sociedade Brasileira de Pediatria
REVIEW ARTICLE
Introduction
Adequate care to newborn infants in the delivery room
is essential so as to prevent asphyxial lesions, which
cause neonatal death, and neurological sequelae in those
who survive, impairing their quality of life and of their
families as well.
In February 2000, the committees for neonatal
resuscitation of the American Academy of Pediatrics, of
the International Committee on Resuscitation (Europe,
Canada, Australia, New Zealand, South Africa, Latin
America), of the American Heart Association and of the
World Health Organization developed guidelines for the
recommendation and use of the most efficient resuscitation
procedures based on research data, knowledge and
experience. The recommended practices were then
published in scientific articles and in the Textbook of
Neonatal Resuscitation in 20001,2 and have been taught
through the Neonatal Resuscitation Program of the
Brazilian Society of Pediatrics at a nationwide level.
Nevertheless, despite the wide use of these procedures,
some of them have been performed based on clinical
experience and on animal and adult studies. Thus, there is
controversy over their use in full-term newborn infants3 and
mainly in very low birthweight infants, especially in extremely
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low birthweight ones, i.e., those weighing less than 1,000 g
at birth.4 Infants with such a birthweight correspond to the
95th percentile of a 22-week gestation, to the 50th percentile
of a 27-week gestation and to the 10th percentile of a 30-
week gestation.5 Thus, this article aims to discuss the main
controversial issues related to the resuscitation of extremely
preterm infants in the delivery room.
At present time, the procedures carried out during
neonatal resuscitation include: - maintaining the body
temperature by way of heat treatment; - maintaining
airway permeability through correct head and neck
positioning; aspiration of the mouth, nose and, if necessary,
of the trachea; - mechanical ventilation using positive air
pressure with a balloon and mask or balloon and tracheal
tube; - maintaining circulation by applying cardiopulmonary
resuscitation and administering drugs or fluids. All these
procedures are performed based on integrated evaluation of
three signs: breathing, heart rate and color.1,2
Maintenance of body temperature
The first step to be taken in the delivery room is to
maintain the newborns body temperature by using warm
fields and radiant heat. The drying process prevents heat
loss from evaporation and conduction and is also a tactile
stimulus to the onset of breathing.1,2
Preterm infants are highly susceptible to cold stress,
since their ratio between body area and weight is large,
which results in hypothermia, hypoxemia and acidosis. To
reduce heat loss in those weighing less than 1,000g, a
transparent PVC film has been used. After drying them with
warm fields under radiant heat, the infant can be totally
wrapped in PVC, except the face, and then resuscitation
maneuvers can be applied.6 In addition, it has been shown
that in case of patients with 23 to 27 weeks of gestational
age, wrapping only the trunk and limbs in a polyethylene bag
(20 x 50 cm) immediately after birth, without previous
drying, under radiant heat, reduces heat loss.7 These
practices are inexpensive, easy to use and efficient and do
not interfere with resuscitation procedures. On the other
hand, special care should be taken in order to avoid
hyperthermia since it is associated with respiratory
depression.8,9
A study conducted in 1998 in 56 Canadian maternity
wards showed that hypothermia and hyperthermia are
frequent in the delivery room. Neutral temperature could
not be obtained in 52% of 520 newborns at the end of
resuscitation, so 27% had hypothermia and 25%
hyperthermia.10 As to the prevention of hypothermia
(< 36 oC), some institutions have employed radiant heat
over the cradles of patients weighing less than 1,500 g or
chemically-heated mattresses, whereas others have placed
the patients and the mattress inside plastic bags, besides
placing caps, which are maintained up to the admission to
the neonatal intensive care unit. Multidisciplinary teams of
five U.S. neonatal units managed to reduce hypothermia
from 40% in 1997-1999 to 15% in 2000-200111 by
implementing these practices, with the aim of reducing the
incidence of peri-intraventricular hemorrhage.
Another aspect related to hypothermia concerns its
therapeutic action due to the possible reduction of brain
damage in hypoxic-ischemic encephalopathy. With the
purpose of verifying whether systemic hypothermia, initiated
before six hours of life and maintained for 72 hours, reduces
mortality and/or developmental disorders, controlled and
randomized clinical trials including full-term newborns with
moderate or severe hypothermia are underway. Up to the
moment, these publications have only provided data on the
safety of the procedure in full-term newborns.12,13 With
regard to its possible application to preterm infants, no
studies have been published yet.
Airway aspiration
Immediately after birth, the infants head is positioned
with the neck slightly extended and secretions are aspirated
in order to allow for airway permeability. The mouth and
then the nostrils are delicately aspirated with a tracheal
tube no. 6-8, coupled to a vacuum aspirator, under a
maximum negative pressure of 100 mmHg, exercising
caution so as to avoid aspirating the larynx, causing
laryngeal spasm and vagal bradycardia and delaying the
onset of respiration.1,2 This procedure has not been
specifically discussed with regard to preterm infants,
however, the neutral position of the head has been a
common practice in the first 72 hours of life for the
prevention of peri-intraventricular hemorrhage in very
low birthweight infants.11
Oxygenation
After maintenance of body temperature and airway
permeability, if the preterm infant is breathing spontaneously,
has a heart rate greater than 100 bpm and central cyanosis,
the use of inhaled oxygen is recommended. The oxygen can
be provided through a mask with side holes, anesthetic bag
or a catheter connected to the source of oxygen at 5 l/min,
which has a concentration close to 100%. On top of that, if
the newborn has at least one of the following situations:
apnea, gasping, heart rate less than 100 bpm or persistent
cyanosis, despite receiving inhaled oxygen, pressure-
controlled ventilation is indicated. A self-inflating bag with
a 750-ml maximum capacity, connected to the source of
oxygen at 5 l/min and linked to a reservoir is used to achieve
an oxygen concentration of 90 to 100%.1,2
The main controversy investigated in the last few
years has been the minimum concentration of oxygen
necessary to resuscitate a newborn infant at birth. Some
authors have argued about the necessity to use an oxygen
concentration of 100%, recommended in the routine
practice based on studies involving animals and newborn
infants.14,15 This argument results from the concern with
the toxic potential of oxygen, which has already been
observed in full-term asphyxiated newborns in whom a
concentration of 100% was used for resuscitation.16 After
a long period of hypoxia, the tissue level of hypoxanthines
is high. When hypoxanthines combine with oxygen in the
presence of xanthine-oxidase, a large amount of free
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radicals is produced, which may oxidize enzymes, inhibit
protein and DNA synthesis, reduce the production of
surfactant and cause lipid peroxidation with consequent
tissue injury. These oxygen free radicals  superoxide,
hydrogen peroxide and hydroxyl  have been implicated
in the pathogenesis of several diseases that affect the
lungs, brain and other systems of newborn infants,
especially preterm ones. Preterm infants are particularly
vulnerable to lung injury induced by free radicals, since
the antioxidant system develops in the last trimester of
pregnancy. This system includes catalase, superoxide-
dismutase and glutathione-reductase and free radical
scavengers, such as vitamins A, E and C, betacarotene
and glutathione, whose levels are low in preterm infants.17
Therefore, the amount of oxygen free radicals may exceed
the antioxidant capacity of preterm infants and cause
diffuse lung injury which, if not treated, leads to the
development of diffuse alveolar injury and to progressive
pulmonary dysfunction. Another concern is with high
oxygen pressure in extremely preterm infants and its
contribution to the incidence of retinopathy of
prematurity.18
It is very likely that the low oxygen concentration during
neonatal resuscitation will lead to a low production of free
radicals and will reduce tissue injury after reperfusion.19 In
the 1960s, experiments with rabbits showed that an increase
in arterial oxygen pressure from 50 mmHg to hundreds of
mmHg caused little change in pulmonary vasodilation,
provided that there was no malformation or lung immaturity,
and that room air ventilation was appropriate to ensure
alveolar diffusion of oxygen to the bloodstream.20 In addition,
porcine studies show that room air resuscitation decreases
vascular pulmonary resistance similarly to that with an
oxygen concentration at 100%.1,22
The only clinical trial involving newborn infants with
gestational age less than 33 weeks assigned to receive
ambient air or oxygen during initial stabilization showed
a high cerebral blood flow in the first group in the second
hour of life. Since PaCO2 was similar in both groups,
exposure to different oxygen concentrations was the only
explanation to this finding, although the consequences
are unknown.23
A meta-analysis of five clinical trials (three open-
labeled and two double-blind studies) has been recently
published comparing the use of room air with oxygen at
100% in 1,302 newborn infants who needed ventilation,
with a mean weight between 2,400 and 3,400 g and a
mean gestational age of 37 to 39 weeks.24 The time
elapsed between the infants crying and the first breath
was shorter in room air ventilated patients than in those
who received oxygen at 100%. The 5-minute Apgar score
was similar in both groups and so was the incidence of
hypoxic-ischemic encephalopathy, with the lowest
mortality rate at 28 days in patients submitted to room air
ventilation; however, the long-term effect could not be
determined due to methodological limitations of the study
that followed up infants to the age of 12 months.25 The
authors highlight three open-labeled trials carried out in
developing countries and the use of oxygen at 100% when
cyanosis and bradycardia did not resolve in 90 seconds,
necessary in 168 (27%) of 635 patients who had initially
been submitted to room air ventilation.
These authors conclude that room air ventilation may be
initially used in full-term or near-term infants with moderate
asphyxia, but there always should be spare oxygen in case
of resuscitation failure. They underscore that intermediate
concentrations have to be investigated in clinical trials that
should include preterm infants stratified according to
gestational age, with continuous monitoring of oxygen
saturation and heart rate using pulse oximetry in the
delivery room. Moreover, these studies should include
confounding variables, such as cause of respiratory
depression, place of birth and available resources.24 This
view is also shared by other researchers.26-28 These clinical
trials are necessary, as a recent investigation showed that
half of 40 institutions in 23 countries of five continents use
variable oxygen concentrations in the treatment of newborn
infants in the delivery room, whereas the remaining 50%
have used oxygen at 100%.29
From a practical point of view, perhaps the widespread
use of pulse oximetry in the delivery room can help to
quickly reestablish normoxia and attain normal
oxygenation levels throughout the resuscitation process
and also after it.26
Another relevant issue is the use of cold, sometimes dry,
oxygen in the delivery room, which is toxic to the pulmonary
epithelium and may cause inflammatory response.
Researchers emphasize the current different practices in
the delivery room and in intensive care units, where much
more attention is paid to the heating and humidification of
respiratory gases.30
Ventilation
Besides the concern with the ideal oxygen concentration
that should be used for neonatal resuscitation, it is also
important to determine the effects of pressure and volume
during manual ventilation, especially in extremely preterm
infants.
Initially, some aspects of lung mechanics should be
considered in case of preterm infants: functional residual
capacity established within the first respiratory
movements, increase in lung volume and use of positive
end-expiratory pressure (PEEP).
Most of the information about functional residual capacity
at birth derives from studies involving full-term newborns;
however, these concepts cal also be applied to preterm
infants. Upton & Milner31 assessed first positive pressure
ventilations in 30 asphyxiated newborns using 40
movements/minute with a mean inspiratory time of 0.51
second without PEEP and applying the necessary pressure
to obtain ribcage expansion. Of 30 patients, 22 were
preterm with a mean birthweight of 1,760 g (range: 580-
3,980) and a mean gestational age of 33 weeks (26-42). A
mean pressure of 40 cm H2O was observed during the first
breaths (28-60). Thus, half of the patients required a
pressure greater than this value. Ten preterm infants did
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not have functional residual capacity at the beginning, but
this capacity increased after several insufflations, indicating
that an end-expiratory pressure would be necessary to
properly establish it, due to surfactant deficiency. Other
authors,32 when ventilating preterm infants during
resuscitation, began with an inspiratory pressure of 16 cm
H2O and increased 2 cm H2O in every insufflation at
subsequent times. They also prolonged initial insufflation
for 2 to 3 seconds, which probably contributed towards the
development of functional residual capacity and to an
increase in lung compliance. This increase in functional
residual capacity was observed before ribcage expansion,
denoting that at the end of five breaths, the air volume
received by the lung was enough to expand the ribcage
using pressures below 30 cm H2O.
Currently, there are two ways to initiate positive pressure
ventilation at birth. Apparently, the use of lower pressures
with prolonged inspiratory time during the first breath is the
most appropriate. This preference may be related to the
distribution of the inspired volume and to the possible
occurrence of lung injury when high pressures are used,
since high volumes can lead to partial hyperdistension of the
lung parenchyma, mainly in extremely preterm infants.
In neonatal resuscitation, besides establishing the
functional residual capacity, it is necessary to provide
sufficient tidal volume in order to promote appropriate gas
exchange without causing pulmonary hyperdistension. In
practice, the parameter used to monitor the inspiratory flow
is the ribcage movement; however, it is still unknown how
this movement relates to proper alveolar expansion and
ideal tidal volume in a lung that is unevenly expanded.33
Animal studies suggest that the excessive variation of
lung volume or volutrauma can be the major cause of lung
injury.34,35 As ribcage expansion is inversely proportional to
gestational age, the risk of volutrauma in extremely preterm
infants is greater than in older preterm newborns. Therefore,
satisfactory peak inspiratory pressures can produce excessive
tidal volumes, hypocapnia and lung injury. This is also a
concern from a neurological point of view, since evidence
has shown an association between hyperventilation and
hypocapnia in preterm infants and abnormal neurological
development with occurrence of periventricular leukomalacia
and cerebral palsy.19,36
Studies with preterm sheep demonstrated that only
six manual insufflations of 35 to 40 ml/kg, performed
before surfactant administration and before mechanical
ventilation, are enough to compromise the efficacy of
surfactant replacement. These sheep revealed more lung
injury in the histological analysis, more seriously impaired
lung mechanics and less gas exchange, compared to
those not submitted to manual ventilation at birth.35
Additionally, there is a concern that manual ventilation at
birth in newborns weighing 600 g may provide up to
40 ml/kg and that during the first 5 minutes of life, very
low birthweight infants have more than 100 respiratory
movements with these high levels of tidal volume.19
The increase in lung volume leads to the distension of
pulmonary cells, causing an increase in epithelial and
endothelial permeability and cytokine cascade with
consequent proinflammatory reaction and deterioration of
the lung injury. This also occurs with insufficient ventilation
and is especially worrying in extremely preterm infants with
surfactant deficiency, who are subjected to a
nonhomogeneous lung expansion. Thus, the possibility of
providing an appropriate tidal volume is quite limited during
neonatal resuscitation, since necessary knowledge and
tools have not been currently available.33
In practice, some U.S. neonatal units have monitored
tidal volume and inspiratory pressure in the delivery room
to prevent hyperventilation and have sought to minimize
ribcage expansion by using a tidal volume below 7 ml/kg in
extremely preterm infants.11
In addition to the aspects related to functional residual
capacity and tidal volume, some aspects regarding PEEP
have to be considered in preterm infants. Some evidence
shows that it is important to maintain immature and
surfactant-depleted lungs patent with PEEP in order to
minimize pulmonary edema and cytokine release and then
improve compliance and the response to the surfactant.
Studies with very immature rams have shown that the use
of any PEEP during neonatal resuscitation produces
remarkable improvement in oxygenation. With a PEEP of 8
cm H2O the alveolar-arterial oxygen gradient drops 50%
within the first 10 minutes after birth with a slight increase
in the PaCO2 or adverse effects on arterial pressure associated
with a 25% increase in lung compliance.37
Thus, the purpose of using PEEP in the delivery room is
to prevent lung collapse during expiration and to establish
the functional residual capacity. If PEEP is performed during
resuscitation, it may result in quick improvement of oxygen
and carbon dioxide levels and in less lung injury, especially
in extremely low birthweight infants.
Some authors have recommended the use of nasal
continuous positive airway pressure (CPAP) in the delivery
room as a way to reduce mechanical ventilation support and
the development of bronchopulmonary dysplasia.6,38-41 In
practice, a qualitative survey with 179 U.S. neonatologists
showed that 59% used nasal CPAP and PEEP in the delivery
room, while 63% used nasal CPAP with anesthetic bag and
27% with self-inflating bag with PEEP valve. The mean PEEP
used was 4.7 cm H2O (2-10) in preterm infants and 5.3 cm
H2O (3-10) in full-term newborns.
42
At present, some institutions have shown that the use
of nasal CPAP is feasible and safe when initiated
immediately after birth in preterm infants with less than
28-30 weeks of gestational age.39-41 However, randomized
clinical trials are necessary to show the possible benefits,
treatment criteria and risks of this therapy.43 It should be
highlighted that the recommendations made in the year
20001,2 for the resuscitation of extremely preterm infants
do not contemplate the use of PEEP or CPAP in the delivery
room. Therefore, until new practices are defined, probably
in 2005, the minimum pressure and volume possible must
be used to provide appropriate ventilation by continuous
observation of ribcage expansion in extremely low
birthweight infants.
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Aside from the pathophysiological aspects of pulmonary
disease in preterm infants, which hinders adequate ventilation
at birth, one of the topics that has been widely discussed
recently deals with the available material for appropriate
neonatal ventilation. No randomized clinical trials exist
comparing different pieces of equipment, which currently
consist of anesthetic and self-inflating bags,1,2 commercially
available in our setting, the T- tube recommended in
Europe44,45 and the Neopufffi infant resuscitator used in
Australia and New Zealand.46
The characteristics related to the use of self-inflating
bags have been questioned, because in spite of automatic
re-expansion and ease of use, it is not possible to provide
a constant peak inspiratory pressure, as this depends on the
force and speed of balloon compression, on the amount of
air leakage, especially between face and mask, and on lung
compliance. The maximum inspiratory pressure that can be
administered is limited by the escape valve activated at 30-
40 cm H2O in order to avoid barotrauma, an important cause
of acute ands chronic lung injury in preterm infants.
Nevertheless, it has been demonstrated that these valves
are activated in a variable pressure gradient. Additionally,
self-inflating bags do not provide PEEP and do not allow for
an inspiratory time greater than one second.30
With regard to anesthetic bags, they have to be connected
to a gas supply and a manometer, can provide inspiratory
pressure and allow the use of PEEP. However, the applied
pressures can vary considerably due to the difficulty in
controlling the gas flow and balloon compression
simultaneously. The difficulty related to the use of this type
of balloon may result in extremely elevated peak inspiratory
pressure and PEEP.
Another resuscitator used in the delivery room is the T-
tube connected to the face mask or to the tracheal cannula,
which has been used in Europe. Insufflation is obtained due
to the interruption of air leakage through the ventilation
hole by the pressure of the resuscitators thumb. There is a
valve to limit the inspiratory pressure, allowing for prolonged
inspiratory time.44,45 In addition, the Neopufffi infant
resuscitator, used in Oceania, allows for the use of constant
inspiratory pressure and PEEP, which may be adjusted
according to the patients clinical response.30,46
Although these resuscitators provide inspiratory pressure,
the use of tidal volume depends mainly on the lung compliance
that varies over time according to lung expansion. Thus, the
great concern with the use of manual resuscitators is related
to not knowing the tidal volume provided during ventilation.
Maybe different types of manual resuscitators should be
developed based on the etiology of breathing difficulty,
since extremely preterm infants differ from full-term infants
because they have intrinsic pulmonary disease with
immaturity and sometimes infection, making it difficult to
establish an appropriate lung volume due to low compliance
and surfactant deficiency.30
These facts can have important clinical implications
for the resuscitation of preterm infants in the delivery
room. Ideally, volutrauma should be prevented through
normalization of functional residual capacity, improvement
of insufflation and pulmonary blood flow, using the least
possible ventilatory support to maintain oxygen release
into tissues. However, these goals cannot be easily
measured at birth.
This way, further studies are necessary to establish
the adequate parameters of inspiratory pressure, lung
volume and PEEP in order to properly ventilate extremely
low birthweight infants. The advantage of using nasal
CPAP in the delivery room also has to be determined
through randomized clinical trials. Furthermore, manual
resuscitators should be developed to optimize the use of
these parameters and to minimize lung injury at the
beginning of extrauterine life.
Tracheal intubation
Tracheal intubation, in the delivery room, of extremely
low birthweight infants is not universally accepted in the
literature. German studies compared mortality and morbidity
of patients with gestational age above 23 weeks and
birthweight less than 1,000 g cared for in the delivery room
in two distinct periods, when different practices were adopted
immediately after birth. In the first period, 1994, all newborns
(n = 56) presenting with mild respiratory discomfort were
intubated soon after birth. In the second period, 1996, all
patients (n = 67) received continuous pressure of 20-25 cm
H2O through a nasopharyngeal tube followed by CPAP of
4-6 cm H2O to establish the functional residual capacity and
prevent intubation and mechanical ventilation. None of the
123 patients received prophylactic surfactant in the delivery
room. In 1994, 84% of newborns were intubated in the
delivery room and 7% did not require intubation or mechanical
ventilation during their hospital stay. In 1996, 40% of the
newborns were intubated in the delivery room and 25%
never required intubation or mechanical ventilation. In the
latter group, 35% received mechanical ventilation due to
respiratory distress syndrome, and the use of the new
technique in the delivery room did not increase morbidity
and mortality. The authors conclude that intubation in the
delivery room should be performed on a case-by-case basis
and used only in patients who need it. Moreover, the
administration of prophylactic surfactant may change these
results due to the necessity of immediate intubation.6
One of the disadvantages of intubation is the presence
of a tracheal cannula which, after crossing the larynx,
eliminates the intrinsic end-expiratory pressure, reducing
intratracheal pressure during expiration and leading to lung
collapse with consequent reduction in lung volume and in
the functional residual capacity.
A study carried out in the United Kingdom followed up
the changes in resuscitation maneuvers in preterm infants
from 1993 to 1997. Ventilation with self-inflating bag and
face mask was replaced by T tube with a pressure-controlled
face mask in 1995. With time, the frequency of tracheal
intubation was cut down to half in patients with gestational
age equal to or greater than 30 weeks, but remained
between 80 and 85% in those with gestational age less than
30 weeks.45
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Another issue related to preterm infant care that has
been discussed is the transportation of the patient requiring
assisted intubation and ventilation to the intensive care
unit. In a recent study, 36 newborns with a mean age of
28 weeks (23-34) and birthweight of 1,180 g (480-4,200)
intubated and ventilated from birth up to their transfer to
the neonatal unit were submitted to continuous monitoring
of the dynamic pulmonary function. They received initial
pressure parameters of 18 cm H2O, PEEP of 5 cm H2O,
inspiratory time of 0.3 seconds with 60 cycles/minute and
FiO2 for oxygen saturation between 90 and 98%. On
admission to the neonatal intensive care unit, 26% had a
PaCO2 less than 30 mmHg, 38% had a PaO2 greater than
100 mmHg, and 20% had hypocapnia with hyperoxia. The
minute/kg ventilation revealed an inverse correlation
with PaCO2: patients with hypocapnia had a mean of
627 ml/kg/minute and those with normocapnia had
402 ml/kg/minute. The authors concluded that the proper
adjustment of minimum ventilatory parameters is quite
difficult in the period between birth and transfer to the
neonatal unit, and , in this case, unintentional
hyperventilation is very common. Thus, special caution
should be exercised to limit minute ventilation during
resuscitation to prevent hypocapnia, which besides
respiratory problems, may result in inappropriate cerebral
autoregulat ion with consequent per iventr icular
leukomalacia, hearing loss and cerebral palsy.47
In addition to the aspects mentioned above, the
recommendation of tracheal intubation in a newborn in
the delivery room must always take into account the
resuscitators ability and the possibility of complications
that include the development of hypoxemia, apnea,
bradycardia, pneumothorax, soft tissue laceration, tracheal
or esophageal perforation and increase in the risk of
infection.1,2 A prospective study conducted at a university
center used video recordings to compare the number of
attempts and the time necessary to obtain a successful
tracheal intubation in the delivery room in two groups:
patients with gestational age less than or equal to 28
weeks and greater than 28 weeks. The procedure was
successful in 54% (20/39) versus 39% (31/78) of the
attempts and in 28 versus 26 seconds, with no statistical
significance, and esophageal intubation was the most
common cause of failure. The authors recommend that
the length of 30 seconds be adjusted, since the attempts
between 20 and 30 seconds were not associated with
bradycardia or cyanosis.48
Currently, it has been demonstrated that preterm
infants with gestational age less than 30 weeks benefit
from prophylactic surfactant given in the first minutes of
life through the tracheal tube,45 without enough time for
the correct positioning of the cannula. Thus, a recent
investigation proposes suprasternal palpation, previously
described in 1975,50 to calculate the correct position of
the tip of the tracheal cannula. This technique, applied to
54 newborns with a mean gestational age of 32 weeks
(range: 24-42) and birthweight of 1,900 g (470-4.400)
allowed determining the exact position of the cannula in
38 (70%) patients, compared to 54 (100%) newborns in
whom the positioning was determined via chest x-ray
(p = 0.0001). The authors state that the advantage of this
technique is that it is simple, quick, noninvasive, safe and
easy to perform in extremely preterm infants due to the
small amount of subcutaneous tissue and cartilage,
resulting in better positioning of the tracheal cannula
before mechanical ventilation and in a smaller chance of
intubation, especially in the right bronchus.51
Still with regard to the correct positioning of the
tracheal cannula, some researchers mention that the
endotracheal monitoring of expired CO2 by means of
color52 or capnography53 may be useful. In 45 patients
(450-4,620 g) intubated in the delivery room and in 21
intubated in the neonatal unit, this technique helped
detect 12 cases of esophageal intubation. The three false-
negative results occurred in patients with severe
respiratory depression.52 The mean time to determine
the position of the cannula was 8–3 seconds through the
CO2
 detector, and 39–15 seconds based on clinical
evaluation. Capnography also distinguished 16 cases of
tracheal intubation and 11 cases of esophageal
intubation,53 with a mean time of 9 seconds (4-26) in
capnography and 30 seconds (25-111) in clinical
evaluation. Even though it is a practical procedure,
precautions must be taken, since these studies only
report some dozens of attempts of intubation, and some
situations such as the following are not considered:
inappropriate pulmonary expansion, reduced pulmonary
blood flow and low tidal volumes, which may interfere
with the interpretation of results.
In cases of failure of tracheal intubation or of inefficient
ventilation with balloon and mask, laryngeal mask airway
has been suggested. However, only newborns with
gestational age greater than 34 weeks have been studied,
so no experience exists with extremely preterm infants.53
The greatest concern with tracheal intubation in
extremely low birthweight infants is the invasiveness of
the procedure, thus requiring a highly skilled and
continuously trained staff to perform it quickly and
efficiently with minimal complications.11,39
Exogenous surfactant
A meta-analysis included eight clinical trials published
between 1991 and 1997 with the aim of comparing the effect
of the prophylactic and therapeutic use of surfactant in
respiratory distress syndrome in preterm infants with
gestational age less than 30-32 weeks.49 All trials were
randomized and controlled using natural surfactant, which
was administered via the endotracheal tube before the first
respiratory movement or immediately after intubation or
stabilization. The results showed reduction in the incidence
of pneumothorax (6 studies with 2,515 patients; relative
risk of 0.62 and 95% confidence interval of 0.42-0.89), of
pulmonary interstitial emphysema (six studies with 2,037
patients; RR 0.54; 95%CI  0.36-0.82), of bronchopulmonary
dysplasia or death associated with the use of prophylactic
surfactant (8 studies with 2,816 patients; RR 0.85; 95%CI
 0.76-0.95). No difference was observed as to the incidence
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of necrotizing enterocolitis, patent ductus arteriosus, severe
peri-intraventricular hemorrhage or retinopathy of
prematurity. In newborns with less than 30 weeks, there
was a reduction in the risk of neonatal death (seven studies
with 1,822 patients; RR 0.62; 95%CI  0.49-0.78) and of
the risk of death or bronchopulmonary dysplasia (eight
studies with 2,025 patients; RR 0.87; 95%CI  0.77-0.97).
The meta-analysis suggests that for every 100 patients who
receive the prophylaxis, there is a reduction of two
pneumothoraces and five deaths.
One of the main investigations55 about surfactant
administration in the delivery room was carried out in three
U.S. maternity wards where 651 preterm infants with an
estimated gestational age between 240/7 and 286/7 weeks
were randomized into two groups prior to birth. The first
group consisted of patients who received a bolus of 3 ml
(105 mg) of natural surfactant via the endotracheal tube
immediately after birth and before positive pressure
ventilation. The second group was submitted to tracheal
intubation within the first 9 minutes of life and to resuscitation
procedures, if necessary, and at 10 minutes of life, 3 ml of
surfactant was given in four doses of 0.75 ml. All patients
received up to three additional doses of therapeutic surfactant
when they developed respiratory distress syndrome. Survival
up to hospital discharge was similar in both groups (76
versus 80%), as well as the need for oxygen therapy up to
36 weeks of postconceptional age (18 versus 13%). Since
then, these authors recommend the administration of
prophylactic surfactant around the 10th minute of life, after
resuscitation maneuvers, in preterm infants with gestational
age less than 29 weeks.
The beneficial effect of the prophylactic use of
surfactant is related to the possibility of mixing it with the
pulmonary fluid, reaching the alveoli before the
establishment of lung injury. However, the disadvantage
is that the patient has to be submitted to tracheal
intubation and that there is a remarkable number of
patients who do not develop respiratory distress syndrome,
i.e., 35 to 55% are unnecessarily treated at a high cost.
Thus, one of the practices currently used in U.S. neonatal
units consists in having a resuscitation team trained to
administer prophylactic surfactant within 20-30 minutes of
life to preterm infants weighing less than1,000 g, gestational
age less than 27 weeks and/or in the presence of respiratory
distress.39 Other units indicate the use of prophylactic
surfactant in patients with less than 30 weeks of gestational
age.11 The teams assess the patients stability according to
four parameters: heart rate equal to or greater than 100-
120 beats/minute, oxygen saturation greater than 89%,
perfusion equal to or less than 3 seconds and mean arterial
pressure equal to or greater than gestational age. Usually,
the two first parameters are more easily verified, and the
main objective is to administer surfactant as quickly as
possible, before 20 minutes of life in stable patients in the
delivery room.
Cardiopulmonary resuscitation
Currently, cardiopulmonary resuscitation is initiated if
after 30 seconds of ventilation and oxygen at 100%, the
newborn has or continues to have a heart rate less than
60 bpm. Cardiac compression is performed at the lower
third of the sternum using the two-thumb method, which
is the most efficient, or using two index fingers and the
middle finger.56 Although there are no data about the
neonatal period, it is recommended that the depth of
compression involve approximately one third of the
anteroposterior dimension of the chest, so as to produce
a palpable pulse. Ventilation and cardiopulmonary
resuscitation are performed in a synchronized way,
maintaining a 3:1 ratio.57 Improvement is considered
when the patient has a heart rate greater than 60 bpm
after vent i lat ion fo l lowed by cardiopulmonary
resuscitation.1,2
The use of cardiac massage has been reported in 8%
of newborns with birth weight between 401 and 1,000 g.58
However, complications related to cardiopulmonary
resuscitation have been reported in extremely preterm
infants, such as liver laceration and rib fractures due to
fragility.1,2
Epinephrine
Epinephrine is indicated for heart rates less than 60
bpm after at least 30 seconds of positive pressure
vent i lat ion and oxygen at 100% fol lowed by
cardiopulmonary resuscitation.1,2 Its main function seems
to be related to peripheral vasoconstriction, improving
oxygen supply to the heart and to the brain during
cardiopulmonary resuscitation.59 It is given in the dose of
0.1-0.3 ml/kg/dose of the solution at 1/10,000 (0.01-
0.03 mg/kg) via endotracheal tube or intravenously. The
intraosseous route is seldom used because the bones are
fragile and the intraosseous space is too small, especially
in preterm infants.60
The dose and route of administration of epinephrine
during neonatal resuscitation have been discussed by some
authors. Experiments with adult animals have shown that
the beneficial effect of epinephrine is mediated by the alpha-
agonist activity with vasoconstriction instead of the beta-
agonist property with consequent increase in contractility
and heart rate. In animal models and in adult humans, a
dose of epinephrine ten times greater than the conventional
recommended dose improves cerebral blood flow, left
ventricular output and coronary perfusion, as well as the
time of return to spontaneous circulation during ventricular
fibrillation. Nevertheless, as prospective and controlled
studies have not been performed, the initial dose of 1.0 mg
in adults is recommended.61
There are several differences between newborns and
adults as to the use of epinephrine. Firstly, 80% of newborns
do not develop ventricular fibrillation as terminal cardiac
activity. Newborn infants have bradycardia and high doses
of epinephrine do not exert an effect on this condition. On
top of that, in adults with cardiac arrest due to coronary
disease, high doses of epinephrine can help myocardial
perfusion, which is vital to the restoration of spontaneous
circulation. However, in newborns, the terminal heart rate
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results from hypoxia despite a transient increase in the
heart rate and myocardial blood flow. Therefore, in this age
group, the increase in coronary blood flow due to high doses
of epinephrine is not critical to resuscitation success, contrary
to what occurs with adults.
In newborn lambs with asphyxia-induced bradycardia,
the dose of 0.05 to 0.1 mg/kg increases arterial pressure
and heart rate more than the dose of 0.01 mg/kg, but it
is accompanied by lower volume and cardiac output.
Therefore, the dose of 0.1 mg/kg of epinephrine can be
deleterious to newborns. There is a major concern with
preterm infants, since they may develop peri-
intraventricular hemorrhage due to hypertension that
follows hypotension, especially if they receive higher
doses of epinephrine than that which is currently
recommended.62
Due to the lack of knowledge about the dose-response
effect of epinephrine on newborns, lack of evidence that
high doses are efficient during symptomatic bradycardia,
lack of information about the importance of coronary pressure
in newborns and in risks associated with high doses of
epinephrine, a dose of 0.01 to 0.03 mg/kg in the concentration
of 1:10,000 is recommended.61
With regard to the route of administration of
epinephrine, the same effects are obtained with an infusion
of 0.1 mg/kg via the tracheal tube and of 0.01 mg/kg
intravenously, but with different cardiovascular
repercussions that may have important implications for
neonatal resuscitation, especially in preterm infants. The
peak and length of hypertension are higher when a dose
of 0.1 mg/dl is given via the tracheal tube compared to a
dose of 0.01 mg/dl per intravenous infusion. As previously
mentioned, the levels of arterial blood pressure in preterm
infants may predispose to peri- intraventricular
hemorrhage.
The fact that the lung is hypoperfused does not interfere
with epinephrine absorption via the endotracheal tube, as
demonstrated in lungs of newborn lambs with hypoxic
pulmonary vasoconstriction and reduction in the pulmonary
blood flow at 30%.61
Thus, by considering mainly the deleterious effects
associated with high doses of epinephrine infused via a
tracheal tube in preterm or full-term infants, it is
recommendable to use the dose of 0.01 to 0.03 mg/kg or 0.1
to 0.3 ml/kg of a concentration of 1:10,000, which is the
same as that given intravenously.1,2,61,63
A review has been conducted recently with the following
objectives: to determine the effect of endotracheal x
intravenous epinephrine, the effect of high dose versus a
dose of 0.01 to 0.03 mg/dl and the effect of epinephrine
on full-term newborns x extremely preterm bradycardic
infants on mortality and morbidity. The authors did not
find any randomized and controlled clinical trial and
concluded that the current recommendations for its use in
newborns are solely based on studies with animal models
or human adults. Studies that can determine the effect of
epinephrine on newborns, including extremely low
birthweight ones, are necessary.64
Volume expanders
Volume expanders may be necessary to resuscitate
newborns with hypovolemia. Suspicion exists whenever
there is not an appropriate response to resuscitation
procedures, if there is blood loss or if there are signs of
hypovolemic shock, such as pallor, poor perfusion, and
weak pulses. The expander of choice is the isotonic crystalloid
solution  saline solution 0.9% or Ringers lactate solution-
in the initial dose of 10 ml/kg via umbilical intravenous
administration in 5 to 10 minutes.1,2
Although this practice is used, there are no investigations
about the administration of crystalloids in newborns during
resuscitation in the delivery room. The publication that gets
closest to the near-birth period describes the treatment of
41 hypotensive newborns within the first 24 hours of life who
received saline solution (n = 20) or albumin at 5% (n = 21).
The goal was to maintain the mean arterial pressure at 30
mmHg in patients weighing 2,500 g or less at birth, and at
40 mmHg, for at least 30 minutes, if birthweight was greater
than 2,500 g. Expansion with saline solution was as efficient
as that in which albumin was used (85 versus 81%). Thus,
the authors conclude that, due to the low cost and wide
availability of saline solution, it should be the treatment of
choice for treating this condition.65
Albumin should not be used due to its restricted
availability, to the risk of infection and to the association
with myocardial injury and an increase in neonatal
mortality.66,67
Sodium bicarbonate
Another controversial drug used for neonatal resuscitation
is sodium bicarbonate, since no convincing evidence exists
in favor of its use, mainly in preterm infants with gestational
age less than 32 weeks.
Sodium bicarbonate is only indicated during prolonged
resuscitation, when the newborn does not respond to
other therapeutic measures. The dose to be infused in no
less than 2 minutes is of 2 mEq/kg of the solution at 4.2%
(0.5 mEq/ml).1,2
For many years acidosis was treated with bicarbonate
before the administration of epinephrine, due to the reduced
response to catecholamines during acidosis. However,
several studies have cast some doubt on the use of
bicarbonate during hypoxic lactic acidosis, since this drug
may lead to a lower cardiac output, lower arterial blood
pressure and lower intramyocardial pH. As the correction of
acidosis depends on the elimination of CO2, if it remains in
the bloodstream, it will cross the cell membranes and will
increase the production of hydrogen radical, worsening
intracellular acidosis and myocardial activity, even with an
increase in arterial pH. Elimination of CO2 depends on
ventilation and pulmonary blood flow. When sodium
bicarbonate is given to an inadequately ventilated patient,
there will be accumulation of CO2. If cardiorespiratory
arrest occurs, venous pH will increase and little blood will
reach the lungs in order to eliminate the CO2 . Moreover,
hypercapnia prevents the gradient from cellular CO2 to the
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intravascular one, making CO2 difficult to eliminate and
worsening intracellular acidosis. Therefore, the
administration of sodium bicarbonate should always be
followed by efficient ventilation.61
Other possible complications of sodium bicarbonate
infusion are hypernatremia and peri-intraventricular
hemorrhage in preterm infants.68 The undiluted sodium
bicarbonate solution contains 2,000 mOsm/l, which is
extremely hypertonic and independently associated with
higher mortality even after a successful resuscitation.
Hyperosmolarity can reduce aortic diastolic blood pressure,
increase right atrial pressure and decrease lung perfusion.69
Moreover, the abrupt elevation of arterial CO2 pressure acts
on cerebral arterioles increasing brain perfusion and
consequently resulting in hemorrhage. Some authors
consider that an adequate infusion of volume expanders
corrects metabolic acidosis as efficiently as does bicarbonate,
without the risks of sodium overload and hyperosmolarity,
and suggest that sodium bicarbonate not be used for
neonatal resuscitation.70
The only randomized and controlled clinical trial was
conducted in India and assessed the effect of sodium
bicarbonate in 55 newborns with asphyxia at birth: 28
patients (15 preterm infants) who received 4 ml/kg of
sodium bicarbonate (1.8 mEq/kg) in 3-5 minutes and 27
patients (20 preterm infants) who received 4 ml/kg of
dextrose at 5%. The groups were comparable as to the
application of cardiopulmonary resuscitation (44 versus
39%), to the administration of epinephrine (37 versus
25%) and of volume expander (22 versus 11%). Despite
the fact that the performed procedure did not follow the
currently recommended international standards,1,2 the
study showed that the incidence of hypoxic-ischemic
encephalopathy, brain edema and mortality were similar
in both groups, thus concluding that the administration of
bicarbonate did not improve the immediate neurological
prognosis and survival.71
Thus, when taking into account risks and laboratory
evidence of deleterious effects of sodium bicarbonate during
resuscitation, one suggests that it be used only in cases of
prolonged resuscitation when other measures fail. It is
advisable to administer it very slowly in well-ventilated
patients, who after receiving epinephrine and volume
expander, have not shown an appropriate response.1,2
Ethical aspects
The advancements in obstetric interventions and the
introduction of new technologies that allow preterm
newborns to have better survival also predispose newborns
to abnormal neuropsychomotor development, which is
inversely proportional to gestational age. Many of these
patients who used to be regarded as hopeless have
survived nowadays. This shows the necessity to have an
ethical discussion about the onset of resuscitation in the
delivery room, which includes moral and legal issues with
great emotional and financial impact on families, health
professionals and society.72
The resuscitation of an extremely low birthweight
newborn proves controversial with the reduction of
birthweight and gestational age, and most studies on
survival contemplate only weight. Resuscitation was
assessed in 118,448 patients with birthweight between
500 and 1,500 g born between 1991 and 1999 in 362
neonatal intensive care units (325 from the USA, six from
Canada and 31 units from 17 other countries). Considering
the range between 501 and 750 g, the survival rate that
was 47% in 1991 reached 55% in 1999, whereas in the
range between 751 and 1,000 g, it increased from 80%
(1991) to 85% (1999).73
In 1995 and 1996, the in-hospital survival of 4,438
newborns from 14 university centers affiliated with the
National Institute of Child Health and Human Development
Neonatal Research Network was 11, 29, 63, 74, 86 and
89%, respectively for weight ranges of 401-500 g, 501-
600 g, 601-700 g, 701-800 g, 801-900 g and 901-1.000 g.74
Also in our setting, several neonatologists have
published studies carried out at public hospitals. A
prospective study involving 1,416 very low birthweight
infants, conducted between 1998 and 1999 by the Brazilian
Neonatal Research Network, consisting of eight neonatal
intensive care units of teaching hospitals located in six
towns of the states of Rio de Janeiro (one unit), Sªo Paulo
(five units) and Rio Grande do Sul (two units) found in-
hospital survival rates of 25 and 64%, respectively, for
the groups of 500-749 g and 750-999 g.75
A cohort study including 258 extremely preterm infants
with gestational age between 24 and 30 weeks born
between 1998 and 2003 at a private hospital in the city of
Sªo Paulo, where all mothers have prenatal care, revealed
no survival in those weighing less than 500 g, a 40%
survival in 25 patients weighing between 500 and 599 g
at birth, 36% in those between 600 and 699 g (n = 36),
65% in the 700-799 g group (n = 71), 77% in patients
with 800-899 g (n = 66) and 75% in those between 900
and 999 g (n = 60).76
These studies show that the survival of extremely
preterm infants varies with age and depends on the place
of birth, and that it should be continually assessed and
compared with national and international da ta, since
these assessments help guide parents and physicians on
how to manage resuscitation in the delivery room.
Although weight is an accurate measure that can be
obtained immediately after birth, its reliability in predicting
feasibility is limited. For instance, a preterm infant weighing
750 g can be regarded as appropriate for the gestational
age of 22 to 26 weeks, but this four-week difference
allows for survival rates between 0 and 66% according to
U.S. data.70,77 Therefore, the use of gestational age is
considered a better parameter than birthweight to
determine feasibility.
A review of 32 studies carried out in industrialized
countries of North America , Europe and Asia with preterm
babies born between 220/7 and 256/7 weeks in 1990 to 1996
showed an in-hospital survival rate of 3.4% in 1,208
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patients of 220/7 to 226/7 weeks, 21% in 1,946 patients of
230/7 to 236/7 weeks, 46% in 1,623 patients of 240/7 to 246/7
weeks and 66% in 4,355 patients of 250/7 to 256/7weeks.78
With regard to gestational age, data collected between
1998 and 2003 about infants born at a private hospital of the
city of Sªo Paulo, where all mothers have prenatal care,
revealed an in-hospital survival, as follows: 23 weeks 
absent, 24 weeks - 36% (12 survivors/33 live births); 25
weeks - 57% (21/37); 26 weeks - 62% (38/61); 27 weeks
- 55% (17/31); 28 weeks - 76% (32/42); 29 weeks - 79%
(26/33) and 30 weeks - 91% (19/21). In this study, the
lengthening of pregnancy for one week, from 24 to 25
weeks, increased the chances of survival by 60%.76
In practice, unfortunately, age is not precisely known
in a remarkable number of patients. In addition, neonatal
clinical assessment of gestational age using the Ballard79
score for the age between 22 and 28 weeks can also be
inaccurate in 1.3 up to 3.3 weeks.80 It should be
underscored that the clinical sign of fused eyelids may be
observed in approximately 20% of live births with
gestational age between 24 and 27 weeks.79 These facts
can interfere with the decision-making process in the
delivery room.
It seems advisable to recommend that resuscitation
should be performed if the diagnosis of gestational age has
not been previously established. The wait and see strategy
before starting resuscitation should be eliminated, since a
delay in the procedures can cause cold stress injury,
hypoglycemia, hypotension and hypoxemia in newborn
infants, increasing mortality and morbidity.70
In addition to survival aspects, data about development
should be considered in the decision-making process
including parents and physicians. Vohr et al.81 assessed
1,480 extremely low birthweight infants born between
1993 and 1994 up to 18-22 months of postconceptional
age. Two thirds had a rate below 85 on Bailey psychomotor
developmental index and one third had a rate below 70 in
the assessment of mental development, with a 49%
incidence of one or more disorders (cerebral palsy, mental
retardation or deafness). It is known that at the age of 5
years, the chances of extremely preterm infants having
learning disabilities is threefold when compared to full-
term newborns.82
Shankaran et al.83 specifically evaluated 246 survivors
out of 1,016 live births between 1993 and 1999 up to 18-22
months of corrected age. These patients were aged 24
weeks or less, weighed 750 g or less at birth and had a 1-
minute Apgar score equal to or less than 3. Of 246 survivors,
30% had cerebral palsy, 5% presented hearing loss and 2%
were blind. Bailey mental development index was below 70
in 46% of the infants and the psychomotor score was less
than 70 in 36% of them. Thus, mortality and morbidity are
very high in this group of patients, and this information
should be shared with parents in the decision-making
process, whenever possible.
Even though no common agreement exists as to how
small, small is, several studies conducted among health
professionals show they are unanimous about the unfeasibility
of resuscitation in infants with less than 23 weeks of
gestational age.78 The Canadian Pediatric Society and the
Society of Obstetricians and Gynecologists of Canada
recommend the following: not performing resuscitation in
concepti with less than 23 weeks of age; deciding together
with the family about the cases of 23 and 24 weeks and
performing resuscitation in patients older than 25 weeks.84
Literature data confirm that resuscitation should not
be indicated for patients aged less than 23 weeks or
weighing less than 400 g.1,2,78 After this period, if time
allows so, parents should be informed about the
implications of resuscitation procedures, including the
possibility of sequelae from diseases associated with a
specific gestational age. Moreover, the outcome of
newborns in a certain neonatal unit should also be included
in resuscitation decisions. Each clinical case must be
analyzed separately, always trying to establish adequate
communication between parents, obstetricians and
pediatricians in order to decide whether resuscitation is
appropriate. Most physicians agree that the delivery room
is the proper place for life and death decisions.70
In our setting, no specific recommendations have
been published by Bioethics Committees regarding
minimum gestational age or the presence of congenital
anomalies that preclude neonatal resuscitation in the
delivery room. Maternity wards should collect information
about the success and failure of resuscitation procedures
in the delivery room, as well as data on survival, based on
gestational age, birthweight and presence of congenital
anomalies, so as to compare them with literature data,
discuss them and define their own practices with regard
to these patients.
Another ethical aspect that should be considered is the
time for discontinuation of resuscitation procedures in the
delivery room.
A study carried out by the Vermont Oxford Network
including 196 neonatal intensive care units where 12,983
preterm infants weighing between 401 and 1,000 g born
between 1994 and 1996 were assessed, revealed an 8%
frequency of cardiopulmonary resuscitation in the delivery
room. The comparison of 1,157 patients submitted to
cardiopulmonary resuscitation or who received epinephrine
with 10,826 patients who did not receive these treatments
showed a survival rate of 54 and 75%, respectively.
However, when patients were grouped according to their
birthweight, survival without severe peri-intraventricular
hemorrhage was similar (16%) in 496 preterm infants
weighing between 401 and 500 g with and without
cardiopulmonary resuscitation and/or epinephrine. In
those weighing between 501 and 750 g, survival amounted
to 37% among those who received cardiopulmonary
resuscitation and/or epinephrine and to 54% in those who
did not receive these treatments. In those weighing
between 751 and 1,000 g, a rate of 56% was observed in
those who required cardiopulmonary resuscitation and/or
epinephrine and 84% in those who did not need it. Thus,
most extremely preterm infants who require
cardiopulmonary resuscitation and/or epinephrine at birth
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survive with no evidence of severe peri-intraventricular
hemorrhage. As to the prognosis of long-term outcomes,
specific studies should be conducted in newborns submitted
to these procedures.58
Literature data reveal that the resuscitation of a newborn
after 10 minutes of asystolic cardiac arrest resulting in
survival or survival without severe sequelae is quite
improbable.70,85,86 Resuscitation can be suspended after
15 minutes of absent heart rate despite the appropriate use
of all resuscitation procedures available.1,2,87
Final remarks
Due to controversy and lack of information about
several resuscitation procedures used in extremely preterm
infants, there have been a lot of animal studies and
controlled randomized trials. Perhaps the next international
consensus, which has been underway and whose
publication is expected for December 2005, will include
new practices and place emphasis on aspects related to
oxygenation and ventilation of extremely low birthweight
infants in the delivery room.
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